Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

NCT01534637 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Extrahepatic Bile Duct Cancer
Nausea
Vomiting
Stage II Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IV Pancreatic Cancer

Interventions

DRUG: aprepitant
DRUG: gemcitabine hydrochloride
DRUG: capecitabine
DRUG: fluorouracil
PROCEDURE: radiation therapy
OTHER: questionnaire administration
PROCEDURE: quality-of-life assessment
PROCEDURE: nausea and vomiting therapy
PROCEDURE: management of therapy complications

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]
[object Object]